Transparency in risk regulation : the case of the European Medicines Agency
Transparency has risen to prominence in risk regulation leading government authorities in Europe and North America to introduce an avalanche of new policies. While transparency promises to achieve many instrumental objectives, there is insufficient empirical evidence on the effectiveness of the actu...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.718623 |